BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Höpfner M, Schuppan D, Scherübl H. Targeted medical therapy of biliary tract cancer: Recent advances and future perspectives. World J Gastroenterol 2008; 14(46): 7021-7032 [PMID: 19084910 DOI: 10.3748/wjg.14.7021]
URL: https://www.wjgnet.com/1007-9327/full/v14/i46/7021.htm
Number Citing Articles
Joshua A. Roth, Josh J. Carlson. Cost-Effectiveness of Gemcitabine + Cisplatin vs. Gemcitabine Monotherapy in Advanced Biliary Tract CancerJournal of Gastrointestinal Cancer 2012; 43(2): 215 doi: 10.1007/s12029-010-9242-0
Tobias Kiesslich, Christian Mayr, Julia Wachter, Doris Bach, Julia Fuereder, Andrej Wagner, Beate Alinger, Martin Pichler, Pietro Di Fazio, Matthias Ocker, Frieder Berr, Daniel Neureiter. Activated hedgehog pathway is a potential target for pharmacological intervention in biliary tract cancerMolecular and Cellular Biochemistry 2014; 396(1-2): 257 doi: 10.1007/s11010-014-2161-9
Usha Dutta. Gallbladder cancer: Can newer insights improve the outcome?Journal of Gastroenterology and Hepatology 2012; 27(4): 642 doi: 10.1111/j.1440-1746.2011.07048.x
Mai-Lan Ho, Christine M. Peterson, Vamsidhar R. Narra. Abdominal Imaging2011; : 890 doi: 10.1016/B978-1-4160-5449-8.00086-X
Beverly A. Teicher. The Tumor Microenvironment2010; : 711 doi: 10.1007/978-1-4419-6615-5_31
Sanjeev K. Maurya, Mallika Tewari, Raghvendra R. Mishra, Hari S. Shukla. Genetic abberations in gallbladder cancerSurgical Oncology 2012; 21(1): 37 doi: 10.1016/j.suronc.2010.09.003